Similarly, therefore, we suggest that S100A4-driven alteration of preexisting vasculature may play a critical role in GBM progression, perhaps by accessing an alternative tumor blood supply in the presence of VEGFA. The gene discussed is VEGFA; the disease is neoplasm.